Funding and People - Articles

Wuhan Mayor, British Consul-General, AZ, BP, Deloitte, ThoughtWorks, CBBC and Team Kapital are speakers at digital conference

Wuhan Mayor, British Consul-General, AZ, BP, Deloitte, ThoughtWorks, CBBC and Team Kapital are speakers at digital conference

The China Britain Business Council (CBBC) coordinated an important event this week: a digital conference Chaired by the Mayor of Wuhan Zhou Xianwang, British Consul-General Gareth Hoar, CBBC Chief Exec Matthew Rous and an experts panel made up of Laurence Huang VP of AstraZeneca China, Ying Jiang Asia-Pac President of Deloitte, Zhiqiang Zhang Global VP of BP, Song Zhang GM of ThoughWorks China and Dr Simon Haworth Director of CompanDX/intellomx, Team Kapital, DynastyBio and the Sino-UK Fund.

Continue Reading →

China, Britain and The Dangerous Oaf

China, Britain and The Dangerous Oaf

Where now for our promising life sciences and medtech relationship with China and the Chinese? The virus crisis seems to have polarised our opinion of them but strengthened their opinion of us.

ARTICLE FIRST PUBLISHED IN Business Weekly, Guest blog: 15 May 2020

China’s appetite for UK health technology has never been greater. Investment capital awaits us in China if we could only access it, and the vast and growing Chinese market offers us the opportunity ...

Continue Reading →

Better Startups? Bring back the Grand Tour

Better Startups? Bring back the Grand Tour

The great country houses of Britain are full of beautiful art from other countries, but the UK’s great technology clusters have to paint their own. It is time to start thinking ahead and to put this right because successful startups are the masterpieces of today. Technology is the artefact of our time.

For 200 years up to around 1840 it was customary for well heeled young men to set off from Britain on a Grand Tour around Europe in search of ...

Continue Reading →

Live with passion

Live with passion

So I managed to fit in a single day’s skiing last Sunday.
Nothing very remarkable about that, you might think, until you learn that I haven’t skied for 20 years despite it being one of my passions in life. The reason for this (previously) sad state of affairs is a long story but the Lesson Learned was as obvious as the skis on my feet: if you have a passion in life, in business or in pleasure, then don’t let ...

Continue Reading →

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

So the global pharma and biotech industry still has a pipeline problem: cost per new drug is sky rocketing, volume of new approvals continues to decline, and the influx of likely looking discovery assets is but a trickle. Meanwhile the industry continues to do what it has always done (i.e. implement new team re-structuring or budget allocation ideas), and get what it has always got.

Ready, Fire, Aim?

We still seem to know remarkably little about the drivers governing this pattern. The ...

Continue Reading →
Page 1 of 3 123